Roche Media ١٩ نوفمبر ٢٠٢٥ KaliVir Immunotherapeutics Announces Clinical Trial Collaboration and Supply Agreement with Roche to Evaluate VET3-TGI in Combination with Atezolizumab (Tecentriq®) in Advanced Solid Tumors - Yahoo Finance #Immunotherapeutics Announces #Announces Clinical